news videos images websites wiki

Pfizer NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Thu, 17 Jan 2019 14:00:54 GMTGoogle News
Is Pfizer a Buy?  Motley Fool

It's been a long time since Pfizer (NYSE:PFE) shareholders have seen any revenue growth. Product sales peaked in 2010, but the company now has what it ...

Motley Fool
Court rules against Pfizer in religious discrimination suit  Seattle Times

TRENTON, N.J. (AP) — A woman who said she was fired by a major pharmaceutical company because of her religious beliefs won a court victory Wednesday ...

Seattle Times
CDC to market Pfizer property | Local News  Plattsburgh Press Republican

Rouses Point real estate firm chosen for track record of helping redevelop properties in the area.

Plattsburgh Press Republican
Pfizer to close two manufacturing plants in India  Chemistry World

Pfizer has announced its IKKT and Aurangabad plants in India will close 'as soon as possible in 2019' in a move affecting almost 6% of its manufacturing ...

Chemistry World
Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition  Seeking Alpha

Vascepa is approved as a treatment for hypertriglyceridemia. Despite a slow initial ramp up, sales of Vascepa is increasing drastically. Amarin recently posted.

Seeking Alpha
Here's How Pfizer Gained 20.5% in 2018  The Motley Fool

Shares of Pfizer (NYSE:PFE) gained 20.5% in 2018, according to data from S&P Global Market Intelligence, while its industry was getting hammered.

The Motley Fool
Pfizer Cuts 150 Jobs, Along With Broader R&D Reconfigurations  BioSpace

After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development toward more cutting-edge drugs.

Pfizer closes 5 biosimilar R&D programs, sheds 150 jobs  Becker's Hospital Review

Pfizer is ending five preclinical programs in its biosimilar research and development unit, which will result in 150 employees losing their jobs, according to a ...

Becker's Hospital Review
Amgen And Pfizer: 2 Healthcare Companies We Want To Buy  Seeking Alpha

With 40 positions in our portfolio, it is getting to the point where we have to be selective in deciding which new companies to purchase. The issue is having ...

Seeking Alpha
FDA Agrees To Review Pfizer amyloidosis Treatment  Investor's Business Daily

Alnylam Pharmaceuticals dipped Monday after the Food and Drug Administration agreed to review a amyloidosis treatment from Pfizer in just six months.

Investor's Business Daily
Pfizer inks collaboration deal to use CytoReason's cell-centered models of immune system  FierceBiotech

Pfizer inks deal with CytoReason to use the Tel Aviv-based drug discovery and development company's cell-centered models of the immune system.

Pfizer and the Urge to Merge  TheStreet.com

My stated reason for being in Pfizer all along has been price stability and income....PFE.

Pfizer (PFE) Gains But Lags Market: What You Should Know  Zacks.com

Pfizer (PFE) closed at $42.73 in the latest trading session, marking a +0.85% move from the prior day.

Workers Pfizer will whack at Hospira plants in India to get 'attractive' severance  FiercePharma

Pfizer's decision to close its legacy Hospira plants in Aurangabad and Irungattukottai, India, may come as a surprise to employees, but the U.S. pharma is ...

Investors Buy Shares of Pfizer (PFE) on Weakness  Fairfield Current

Traders bought shares of Pfizer Inc. (NYSE:PFE) on weakness during trading on Wednesday. $269.29 million flowed into the stock on the tick-up and $148.99 ...

Fairfield Current
Pfizer to shut two manufacturing plants in India  Yahoo! Finance News

"Pfizer has conducted a thorough evaluation of the ... sites in India and concluded that due to the very significant long term loss of product demand, ...

Yahoo! Finance News
Pfizer Stock Down On Possible Bid For Amarin  Investor's Business Daily

Amarin stock bounded to a month high Thursday on a report that Dow Jones component Pfizer could be interested in acquiring it. Pfizer stock was down.

Investor's Business Daily
Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer  Zacks.com

Amarin (AMRN) shares rally on rumors of its potential; acquisition by large pharmaceutical company, Pfizer. Speculations are rife about rising M&A activity in the ...

Pfizer seemed like it abandoned neuroscience, then jumped back in  Business Insider

Execs from pharma giant Pfizer shared their strategy for keeping an eye on neuroscience — if not from the front row, then at least from the sidelines.

Business Insider
3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear  The Motley Fool

Pfizer's new CEO, Albert Bourla, provided reasons for shareholders to cheer at the J.P. Morgan Healthcare Conference on Monday.

The Motley Fool
Pfizer consumer health deal will help fuel investments in pharma and vaccines, says GSK CEO Emma Walmsley  CNBC

Pfizer and GSK will combine their consumer health units and plan to spin the joint venture off.

Pfizer: Steady As She Goes  Seeking Alpha

If the sell-off continues, we are looking for strong support at the 200 dma. Dividend gets hiked by 6%. We see more mid increases coming.

Seeking Alpha
Pfizer takeover rumour ignites Amarin shares  PMLiVE

Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified fish oil product Vascepa in ...

GlaxoSmithKline and Pfizer to Merge Consumer Health Units  The New York Times

GlaxoSmithKline and Pfizer plan to merge their consumer-health divisions in a joint venture that the companies said would be the world's largest maker of ...

The New York Times
Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-backed I/O drug  Endpoints News

The checkpoint frenzy in the immuno-oncology sphere has largely focused on blocking the ligand-receptor duo of PD-L1 and PD-1, which cancer cells use to ...

Endpoints News
Rare Value And Growth Stock Opportunity: PG&E Corporation (PCG), Pfizer Inc. (PFE)  Financial Mercury

The shares of PG&E Corporation (NYSE:PCG) has been pegged with a rating of Market Perform…

Financial Mercury
GSK and Pfizer joint venture creates new consumer healthcare giant  Chemistry World

A new $9.8 billion (£7.7 billion) consumer health business has been created by GlaxoSmithKline (GSK) and Pfizer. The joint venture brings together the ...

Chemistry World
Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug  GenomeWeb

NEW YORK (GenomeWeb) – Qiagen said Wednesday that its Therascreen EGFR RGQ PCR kit has been approved by the Japanese Pharmaceuticals and ...

How to Save $650 Million Without Really Trying  The Motley Fool

Pfizer and GlaxoSmithKline join forces with their consumer healthcare businesses, creating plenty of synergies.

The Motley Fool
Stock's Technical Levels under Review – Pfizer Inc. (NYSE: PFE)  Alpha Beta Stock

Pfizer Inc. (NYSE: PFE) stock encountered a rapid change of -1.45% in the last hour of Wednesday's trading session. The stock settled the final trade on $42.11.

Alpha Beta Stock
Analysts' General Perspective On General Electric Company (GE), Pfizer Inc. (PFE)  Financial Mercury

Looking at top Wall Street opinions, General Electric Company (NYSE: GE) has recently made its way into the research list of Vertical Research – signaling that ...

Financial Mercury
Merck/Pfizer's Bavencio flunks second ovarian cancer trial  pharmaphorum

Merck KGaA and Pfizer PD-L1 inhibitor Bavencio has missed the mark in its second ovarian cancer trial in a month, this time failing in previously-untreated ...

New England Professional Planning Group Decreased Position in Pfizer (PFE) by $338,712; Fastenal Co (FAST) Holder Coe Capital Management Has Decreased Its Stake  The Moveefy

Coe Capital Management Llc decreased its stake in Fastenal Co (FAST) by 19.21% based on its latest 2018Q3 regulatory filing with the SEC. Coe Capital ...

The Moveefy
Global Functional Foods Market 2018-19 Pfizer, General Mills, Kellogg, Herbalife  Bitcoin Journal

Functional Foods Market Analysis: This study highlights current dynamics and developments in the “Functional Foods Market“. The report incorporates in-depth ...

Bitcoin Journal
Pfizer Inc. (PFE) Regains Attentions on Diverse Technical Facts  Investing News Update

Pfizer Inc. (PFE) generated 0.16% up depiction by the movements around 20 day SMA. The established trader's sentiment toward the stock has created a trading ...

Investing News Update
Should You Buy PFE Stock on Pfizer’s Joint Venture With Glaxo?  Investorplace.com

A mutual fund stock has many unrelated businesses without the separation of a mutual fund. PFE stock is moving away from this designation.

Pfizer offers severance package to employees of Chennai, Aurangabad units  Business Standard

Pfizer, the US-headquartered pharmaceuticals entity, has sent details of its job severance financial package to staff at its facilities at Aurangabad, Maharashtra, ...

Business Standard
Global Lichen Nitidus Treatment Market | Global Forecasts | Business Players: Pfizer Inc., Novartis AG, Merck & Co., Inc., Sanofi, GlaxoSmithKline plc., AstraZeneca, Hubei Gedian Humanwell Pharmaceutical Co.,Ltd, Farmabios SPA, Horizon Pharma plc.  Journal Dairy

The Global Lichen Nitidus Treatment market is accounted for USD 93.1 million in 2016 growing at a CAGR of 8.8% during the forecast period of 2017 to 2024.

Journal Dairy
Pfizer's Xtandi successful in late-stage study of Xtandi in metastatic prostate cancer  Seeking Alpha

Pfizer (PFE -0.6%) and U.S. commercialization partner Astellas Pharma (OTCPK:ALPMF)(OTCPK:ALPMY) announce positive results from a Phase 3 clinical trial, ...

Seeking Alpha
Holder Telemus Capital Lifted Ares Coml Real Estate (ACRE) Stake; Pfizer (PFE) Stake Lifted by Westpac Banking Corp  The Moveefy

Westpac Banking Corp increased its stake in Pfizer Inc (PFE) by 9.68% based on its latest 2018Q3 regulatory filing with the SEC. Westpac Banking Corp bought ...

The Moveefy
Pfizer (PFE) Holder Capital Advisors Has Decreased Holding by $525,976 as Market Value Rose; Bulldog Investors Has Upped General American Investors (GAM) Holding by $6.49 Million; Stock Declined  The Moveefy

Bulldog Investors Llc increased its stake in General American Investors (GAM) by 389.9% based on its latest 2018Q3 regulatory filing with the SEC. Bulldog ...

The Moveefy
Lowest Cost, Highest Growth :: Pfizer Inc., (NYSE: PFE)  Nyse News Updates

Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price ...

Nyse News Updates
As Pfizer (PFE) Shares Rose, Wedbush Securities Has Decreased by $463,496 Its Holding; Vail Resorts (MTN) Shareholder Financial Counselors Has Cut Position by $395,382  The Moveefy

Financial Counselors Inc decreased its stake in Vail Resorts Inc (MTN) by 12.52% based on its latest 2018Q3 regulatory filing with the SEC. Financial ...

The Moveefy
3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think  The Motley Fool

Pfizer's 6% dividend increase is good news. But here's what makes it even better.

The Motley Fool
American Investment Services Stake in Pfizer (PFE) Has Decreased by $2.52 Million as Stock Value Rose; United Technologies (Put) (UTX) Shareholder Equitec Proprietary Markets Lifted Stake by $1.11 Million  The Yomi Blog

Equitec Proprietary Markets Llc increased its stake in United Technologies Corp (Put) (UTX) by 400% based on its latest 2018Q3 regulatory filing with the SEC.

The Yomi Blog
Baker Ellis Asset Management Trimmed Pfizer (PFE) Holding; Integrated Device Technology (IDTI)'s Sentiment Is 0.85  The Moveefy

Integrated Device Technology Inc (IDTI) investors sentiment is 0.85 in 2018 Q3. It's the same as in 2018Q2. The ratio is without change, as only 126 institutional ...

The Moveefy
Rwc Asset Management Llp Position in Pfizer (PFE) Has Cut as Valuation Rose; As Amazon Com (AMZN) Share Value Declined, Taconic Capital Advisors LP Has Decreased Its Position by $156.23 Million  The Moveefy

Taconic Capital Advisors Lp decreased its stake in Amazon Com Inc (AMZN) by 78% based on its latest 2018Q3 regulatory filing with the SEC. Taconic Capital ...

The Moveefy
2 Pfizer and GlaxoSmithKline's Consumer Health Business  Market Realist

Pfizer's (PFE) consumer health business generated revenues of $2.6 billion during the first nine months in 2018—compared to $2.5 billion during the same ...

Market Realist
Pfizer and GlaxoSmithKline Form a Joint Venture  Market Realist

On December 19, GlaxoSmithKline (GSK) and Pfizer (PFE) entered into an agreement to combine both of their consumer health businesses to form a joint ...

Market Realist
2 This Drug Is Expected to Be a Significant Driver for Pfizer  Market Realist

In the first nine months of this year, Pfizer's (PFE) Ibrance revenue grew 24% YoY (year-over-year) to $3.0 billion from $2.4 billion. US Ibrance sales rose ~6% ...

Market Realist
3 Pfizer and GlaxoSmithKline's Joint Venture: What to Expect  Market Realist

In March, GlaxoSmithKline (GSK) entered into an agreement to buy out a 36.5% stake of Novartis (NVS) in the GlaxoSmithKline-Novartis consumer healthcare ...

Market Realist
How Pfizer's Oncology Business Is Positioned  Market Realist

Pfizer's (PFE) oncology revenue rose ~16% YoY (year-over-year) to $5.3 billion in the first nine months of this year. Its net oncology revenue grew 8% YoY to ...

Market Realist
Pfizer: Recent Developments and Analysts' Recommendations  Market Realist

On December 14, Pfizer (PFE) announced a dividend of $0.36 for the first quarter of fiscal 2019. Pfizer announced that the dividend would be payable to ...

Market Realist
Xtandi and Bosulif Are Expected to Boost Pfizer's Revenue Growth  Market Realist

In the first nine months of this year, Pfizer's (PFE) Xtandi alliance revenue grew ~21% YoY (year-over-year) to $510.0 million. Astellas Pharma and Pfizer jointly ...

Market Realist
Docetaxel Market 2019 Industry Players: Pfizer, Teva, Sandoz, Actavis  Bitcoin Journal

Global Docetaxel Market Report offers a thorough evaluation of the global Docetaxel market along with historic details, industry-standard analysis, factual ...

Bitcoin Journal
Pfizer's Prevnar 13 and Other Developments  Market Realist

Pfizer's (PFE) Prevnar (or Prevenar) 13 is used to prevent pneumococcal diseases. In the first nine months of this year, Prevnar 13 sales grew ~5% YoY ...

Market Realist
Pfizer to raise prices on 41 prescription drugs next year despite pressure from Trump  CNBC

Pfizer will raise prices on 41 of its prescription drugs in January after initially putting off those plans this summer amid pressure from President Trump. The drug ...

Global Erectile Dysfunction(ED) Drug Market 2019-2024: Pfizer, Lilly, Bayer, Johnson & Johnson  Be Internet News

The international market has been eying swelling prosperity in the Global Erectile Dysfunction(ED) Drug Data Survey Report 2025 Market from last decade.

Be Internet News
Global Orally Disintegrating Tablet Market 2019 - Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company  Industry News Alert

The global “Orally Disintegrating Tablet Market” report delivers a comprehensive and systematic framework of the Orally Disintegrating Tablet market at a global ...

Industry News Alert
Non-opioid Pain Patches Market 2018-2023 : Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan NV  Industry News Blog

This report focuses on the global Non-opioid Pain Patches market status, future forecast, growth opportunity, Shares and key players. The study objectives are to ...

Industry News Blog
A Look At Pfizer's Business And Outlook  Forbes

Pfizer (NYSE:PFE) generates its revenues from its Oncology, Cardiovascular, Anti-Infective, Alimentary &Metabolism, Neuroscience, Immunology drugs, along ...

Pfizer's Incoming CEO Represents Pipeline Push Over Dealmaking  Bloomberg

Albert Bourla helped build Pfizer Inc.'s growing pipeline of drugs. Now he'll run the biggest U.S. pharmaceutical company as it banks on that channel for future ...

Drug giant Pfizer offers early retirement ahead of layoffs in memo to employees  CNBC

Pharmaceutical giant Pfizer is offering early retirement to U.S. workers ahead of layoffs early next year, it announced internally to employees. The company ...

4 Things You Need to Know About Pfizer's Restructuring Plans  The Motley Fool

Pfizer (NYSE:PFE) was in the news Wednesday for a second day in a row. On Tuesday, the company announced that it was holding off on price increases for ...

The Motley Fool
Pfizer Is in Breakout-Mode This Fall: Chart  TheStreet

A classic technical breakout in shares of Pfizer points to more upside ahead in this healthcare giant....PFE.

Bain Capital teams with Pfizer to create new neuroscience-focused company  CNBC

Pfizer announced in January it planned to shut down early- and mid-stage neuroscience drug development. But now it's teamed with investment firm Bain ...

Pfizer Is Weighing Sale of $2 Billion-Women's Health Portfolio  Bloomberg

Pfizer Inc. is reviewing options including a sale of its women's health portfolio as the U.S. pharmaceutical giant seeks to focus on developing treatments with ...

Pfizer’s Hospital-Drug Problems Won’t Go Away  Bloomberg

Buying Hospira was supposed to open a bright new pharmaceutical future for Pfizer Inc., but problems from the company's past keep haunting the world's largest ...

Global Knee Bursitis Treatment Market Analysis & Outlook 2018-2025: Novartis, Pfizer, Merck, Amgen, Bayer - Press Release  Digital Journal

United TherapeuticsMarket segment by Type, the product can be split into.

Digital Journal
Where Will Pfizer Inc. Be in 5 Years?  The Motley Fool

With a little momentum at the end of 2018, Pfizer Inc. (NYSE:PFE) could be headed for its best year yet in the 21st century. The big pharma stock is absolutely ...

The Motley Fool
What To Expect From Pfizer's Q3  Forbes

Pfizer (NYSE:PFE) is set to report its Q3 2018 earnings on October 30, and we expect the company to post steady top line growth, primarily led by a ramp up in ...

Pfizer earnings: Looking toward an ambitious 2022 agenda  MarketWatch

Pfizer plans to have up to 30 new drug approvals in the coming years, to make up for losing patent protection on a number of valuable products.

5 Things You'll Want to Know About Pfizer's Future  The Motley Fool

What the big drugmaker's top executives just said about what could be in store for Pfizer.

The Motley Fool
Pfizer Announces Executive Leadership Team  Business Wire

Pfizer Inc. (NYSE:PFE) today announced its executive team that will report to Albert Bourla, incoming Chief Executive Officer, coincident with the com.

Business Wire
Why Pfizer Is Up 19% in 2018 So Far  Motley Fool

It's been a banner year for shares of America's largest pharmaceutical company, but you wouldn't know it by looking at Pfizer's (NYSE:PFE) top line in recent ...

Motley Fool
Pfizer: Stay The Course  Seeking Alpha

New CEO coming on board. His experience lies in innovation. We expect Pfizer to become more focused after the transition especially on acquisitions.

Seeking Alpha
Pfizer Stock Just Hit a 10-Year High: Buy, Sell, or Hold?  Motley Fool

Who would have thunk it? Pfizer (NYSE:PFE) stock is trouncing the S&P 500 index so far in 2018. That's right, shares of the 168-year-old drugmaker have ...

Motley Fool
Pfizer to add 100 oncology R&D jobs, cut others amid restructure  BioPharma Dive

Pfizer will add about 100 new jobs in oncology research and development at its La Jolla, California site, as its Cancer Immunology Discovery unit relocates out ...

BioPharma Dive
Critical Condition: Inside Pfizer’s Drug Supply Problem  Fortune

How a much-touted acquisition by Pfizer, U.S.' biggest pharma co, helped turn the country's chronic drug shortage into a full-blown crisis.

Better Buy: Gilead Sciences, Inc. vs. Pfizer  The Motley Fool

Both have made some strange moves lately, but which is the better stock to buy now?

The Motley Fool
Pfizer’s Departing C.E.O. Will Be Known for the Deals He Didn’t Complete  The New York Times

Ian Read leaves the pharmaceutical company, with eight years of deal-making tarnished by two failed takeovers aimed at moving earnings overseas.

The New York Times
Better Buy: Pfizer Inc. vs. Eli Lilly and Company  Motley Fool

Which of these big American pharma stocks is the better pick right now?

Motley Fool
JP Morgan downgrades Pfizer, saying stock has moved too far, too fast: 'Moving to the sidelines'  CNBC

J.P. Morgan downgraded Pfizer shares to neutral from overweight on Tuesday, warning clients that the stock's rally will likely slow after climbing more than 22 ...

5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock  Zacks.com

Here are five aspects that investors may consider while investing in Pfizer's (PFE) stock.

Pfizer, AbbVie settle Humira biosimilar dispute  Crain's Chicago Business

Another Humira biosimilar is primed to enter the U.S. market in 2023.

Crain's Chicago Business
Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, ex-Facebook President Sean Parker condemns hanging comment, does not request money back  CNBC

Pfizer joins Walmart, AT&T, Boston Scientific, Union Pacific, and Leidos in asking for campaign contributions to be returned.

Dow stocks Pfizer and UnitedHealth could be safety plays amid market volatility  CNBC

In a wild week for the Dow, one corner of the index has proven immune to the worst of the volatility: health care. Dow stocks Pfizer, UnitedHealth and Merck ...

Pfizer: The Outlook Cannot Justify Current Valuation  Seeking Alpha

Pfizer is currently trading at a ~20% discount rate, when taking into account discounted cash flows as well as a multiples analysis. Current estimates of a -5%

Seeking Alpha
Evaluating Pfizer's Growth Plans And Valuation  Seeking Alpha

PFE had a mild downside reaction to a minimal miss on Q3 sales. But the stock remains in an uptrend, having increased its price:sales ratio from 4X to what look.

Seeking Alpha
Pfizer Agrees To Postpone Drug Price Hikes After Trump Tweet  NPR

President Trump is now applauding Pfizer for agreeing to reverse or postpone drug price hikes, a day after he pressured the pharmaceutical giant in a scathing ...

3 Terrible Reasons to Sell Pfizer Stock  Motley Fool

Pfizer's shares have been heating up, but now isn't the time to take profits. Here's why.

Motley Fool
Does the Pfizer Restructuring Make Sense?  Pharmaceutical Executive

The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes ...

Pharmaceutical Executive
Trump Pfizer tweet: Trump gave up concessions to reduce Pfizer prices  Vox.com

President Donald Trump declared war and then victory with drug maker Pfizer within a matter of hours this week, claiming to have successfully convinced the ...

Pfizer rare heart disease drug reduces risk of death by 30 percent in study  Reuters

NEW YORK (Reuters) - Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 ...

Cramer sees Pfizer's reorganization as a 'prelude' to a spinoff of its consumer health-care business  CNBC

Pfizer's announced reorganization could lead to an eventual spinoff of its consumer health-care business, CNBC's Jim Cramer said Wednesday. The drug giant ...

Better Buy: Pfizer Inc. vs. AbbVie Inc.  The Motley Fool

With the first half of 2018 in the rearview mirror, which of these big pharma stocks stands tallest?

The Motley Fool
Pfizer settles New York probe into 'deceptive' copay coupons  Reuters

NEW YORK (Reuters) - Pfizer Inc on Thursday settled charges by New York's attorney general that it misled consumers in its drug copayment coupon program ...

Pfizer CEO on what happened after Trump tweeted  CNBC

Before he even spoke to the president, Pfizer CEO Ian Read said he knew the best move was to defer the drug giant's early July price increases; a Trump tweet ...

Bowing to Trump, Novartis Joins Pfizer in Freezing Drug Prices  The New York Times

Novartis, the Swiss drugmaker, said Wednesday that it would not raise prices on its products in the United States for the rest of 2018, joining Pfizer, which ...

The New York Times
Pfizer Recalls Some Children's Advil Products After Measuring Cup Confuses Milliliters With Teaspoons  Fortune

Pfizer has recalled one lot of its Children's Advil formulation over an overdose worry because of the wrong measuring cup.


Pfizer Videos

15 Things You Didn't Know About PFIZER
15 Things You Didn't Know About PFIZER
Watch CNBC's full interview with GSK CEO Emma Walmsley about the Pfizer merger
Watch CNBC's full interview with GSK CEO Emma Walmsley about the Pfizer merger
Our Immune System - Pfizer - Cortical Studios / Glow Studio
Our Immune System - Pfizer - Cortical Studios / Glow Studio
Pfizer CAC: Quiénes Somos, Qué Hacemos?
Pfizer CAC: Quiénes Somos, Qué Hacemos?
VIAGRA Pfizer unboxing and instruction manual
VIAGRA Pfizer unboxing and instruction manual
Nueva planta de cápsula blanda Pfizer Argentina
Nueva planta de cápsula blanda Pfizer Argentina
Pfizer Comercial Viagra
Pfizer Comercial Viagra
Pfizer pretende ser la farmacéutica más grande
Pfizer pretende ser la farmacéutica más grande
Pfizer company Vizag
Pfizer company Vizag

Pfizer Images

Elbo Signs, Belgium - Pfizer
Elbo Signs, Belgium - Pfizer
Old Pfizer Building ~ Williamsburg Brooklyn. | Favorite ...
Old Pfizer Building ~ Williamsburg Brooklyn. | Favorite ...
Zyvox Dosage & Drug Information | MIMS.com Indonesia
Zyvox Dosage & Drug Information | MIMS.com Indonesia
制药及保健品龙头:辉瑞制药公司Pfizer(PFE) | 美股之家 - 美股投资百科全书
制药及保健品龙头:辉瑞制药公司Pfizer(PFE) | 美股之家 - 美股投资百科全书
Printable Depo Calendar :-Free Calendar Template
Printable Depo Calendar :-Free Calendar Template
Doxycycline - Wikipedia
Doxycycline - Wikipedia
UBROLEXIN 20 Jeringas : Farmacia Veterinaria
UBROLEXIN 20 Jeringas : Farmacia Veterinaria
PfizerLink | At Your Convenience
PfizerLink | At Your Convenience

Pfizer WebSites


Pfizer Wiki

Pfizer Inc. () is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.On December 19, 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant GlaxoSmithKline; the British company will maintain a controlling share (listed at 68%).The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain and fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug.In 2016, Pfizer Inc. was expected to merge with Allergan, Plc to create the Ireland-based "Pfizer plc" in a deal that would have been worth $160 billion. The merger was called off in April 2016, however, because of new rules from the United States Treasury against tax inversions, a method of avoiding taxes by merging with a foreign company. The company has made the second-largest pharmaceutical settlement with the United States Department of Justice.